FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:906-908 March 26, 1998 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Palella, F. J. PubMed Citation

In this issue of the Journal, Palella et al. provide evidence of a massive decrease in morbidity and mortality related to human immunodeficiency virus (HIV) infection.¹ Among 1255 study participants who had at least one CD4+ cell count of fewer than 100 cells per cubic millimeter before enrollment, deaths decreased by 75 percent (from 35.1 to 8.8 per 100 person-years) between early 1994 and mid-1997, and the incidence of AIDS-defining diseases decreased by 73 percent (from approximately 50 to 13.3 per 100 person-years). During this period, progressively more intense antiretroviral therapy was introduced into clinical practice. These improvements occurred not . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Rothbard, A. B., Metraux, S., Blank, M. B. (2003). Cost of Care for Medicaid Recipients With Serious Mental Illness and HIV Infection or AIDS. Psychiatr. Serv. 54: 1240-1246 [Abstract] [Full Text]  
• Price, D. A., Scullard, G., Oxenius, A., Braganza, R., Beddows, S. A., Kazmi, S., Clarke, J. R., Johnson, G. E., Weber, J. N., Phillips, R. E. (2003). Discordant Outcomes following Failure of Antiretroviral Therapy Are Associated with Substantial Differences in Human Immunodeficiency Virus-Specific Cellular Immunity. J. Virol. 77: 6041-6049 [Abstract] [Full Text]  
• Bernard, L., Vuagnat, A., Peytavin, G., Hallouin, M.-C., Bouhour, D., Nguyen, T. H., Vilde, J. L., Bricaire, F., Raguin, G., de Truchis, P., Ghez, D., Duong, M., Perronne, C. (2002). Relationship between Levels of Indinavir in Hair and Virologic Response to Highly Active Antiretroviral Therapy. ANN INTERN MED 137: 656-659 [Abstract] [Full Text]  
• Erb, P., Battegay, M., Zimmerli, W., Rickenbach, M., Egger, M., for the Swiss HIV Cohort Study, (2000). Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus-Infected Cohort. Arch Intern Med 160: 1134-1140 [Abstract] [Full Text]  
• Imamichi, T., Sinha, T., Imamichi, H., Zhang, Y.-M., Metcalf, J. A., Falloon, J., Lane, H. C. (2000). High-Level Resistance to 3'-Azido-3'-Deoxythimidine due to a Deletion in the Reverse Transcriptase Gene of Human Immunodeficiency Virus Type 1. J. Virol. 74: 1023-1028 [Abstract] [Full Text]  
• Ledergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., Kaufmann, D., Sudre, P., Francioli, P., Telenti, A., for the Swiss HIV Cohort Study, (1999). AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral Therapy: The Swiss HIV Cohort Study. JAMA 282: 2220-2226 [Abstract] [Full Text]